510(k) K974261

ACCURUN 135 TOXOPLASMA IGG POSITIVE CONTROL by Boston Biomedica, Inc. — Product Code LJK

K974261 is an FDA 510(k) premarket notification submitted by Boston Biomedica, Inc. for the device "ACCURUN 135 TOXOPLASMA IGG POSITIVE CONTROL". The FDA issued a decision of Substantially Equivalent on Dec 11, 1997. The device falls under product code LJK (Antisera, If, Toxoplasma Gondii), a Class II device regulated under 21 CFR 866.3780. Boston Biomedica, Inc. has 11 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Dec 11, 1997
Date Received
Nov 13, 1997
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Antisera, If, Toxoplasma Gondii
Device Class
Class II
Regulation Number
866.3780
Review Panel
MI
Submission Type
510(k)

Need the full FDA record for Boston Biomedica, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K974261. Report a data issue: hello@regdatalab.com.